/Investor DB

Ahren Innovation Capital — 2021 Investments

2 investments dated 2021 · listed companies and verified rows first · show all

Edifice Healthedificehealth.comin𝕏Apr 2021 · $12M

Edifice Health offers the Inflammatory Age test, a biomarker composite scoring system that measures and monitors a person's inflammatory and immune health for early detection and prevention of chronic disease.

AI & Machine LearningBiotechDigital HealthHealthtechLongevitySan Mateo, US

David Furman, PhD(Co-Founder & Chairman of the Scientific Advisory Board)Mark Davis, PhD(Co-Founder & Scientific Advisory Board Member)inWolfgang Daum(Executive Officer, Director)inDavid Goldberg(CEO)inDavid Furman(Director)

BoardNaveen Krishnan(Director)in

Co-investorsBetter Food VenturesJoyance PartnersPaladin Capital GroupSocial StartsLeaps by BayerVertical Venture Partners

New Culturenewculture.comin𝕏Series A · Nov 2021 · $25M

New Culture produces animal-free dairy cheese products, starting with mozzarella for pizzerias, using food science to replicate the taste, melt, and stretch of conventional cheese.

Climate TechFoodTechSan Leandro, US

Matthew Gibson(Executive Officer, Director)inInja Radman(Founder)inMatt Gibson(Founder)inMatt Gibson Inja Radman(Founder)

BoardSteve Sanger(Director)

Co-investorsAsymmetry VenturesBee PartnersGenoa VenturesS2G InvestmentsSynthesis CapitalCPT Capital+1 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.